Understanding Hlh Disease: A Complete Patient Guide
HLH disease is caused by an uncontrolled immune response that leads to severe inflammation. Common features include persistent fever, enlarged liver or spleen, low blood counts, and abnormal blood test results.
Key Takeaways
- HLH disease is caused by an uncontrolled immune response that leads to severe inflammation.
- Common features include persistent fever, enlarged liver or spleen, low blood counts, and abnormal blood test results.
- HLH may be inherited or triggered by infections, cancer, autoimmune disease, or immune suppression.
- Diagnosis usually requires a combination of symptoms, blood tests, imaging, and sometimes bone marrow testing.
- Treatment focuses on controlling inflammation and addressing the underlying trigger as quickly as possible.
HLH disease, also called hemophagocytic lymphohistiocytosis, is a rare but serious syndrome in which the immune system becomes dangerously overactive. It can affect children or adults, and prompt medical evaluation is important because early treatment can improve outcomes.
Overview: What Is HLH Disease?
HLH disease is the common name for hemophagocytic lymphohistiocytosis, a rare disorder in which the body’s immune system becomes excessively activated and does not switch off properly. Instead of protecting the body in a balanced way, immune cells release large amounts of inflammatory signals, which can damage tissues and organs.
This condition is not a single illness with one cause. Some people develop HLH because of inherited gene changes that affect immune function, while others develop it later in life as a reaction to another problem such as infection, cancer, or autoimmune disease. Doctors may describe these forms as primary (familial) HLH and secondary HLH.
Because HLH can progress quickly, it is considered a medical emergency. At the same time, many of its early symptoms can resemble more common conditions, such as severe infection or inflammatory disease. This overlap is one reason diagnosis can be challenging and why care often involves specialists in hematology, infectious diseases, rheumatology, pediatrics, or critical care.
How HLH Affects the Body
In HLH, certain white blood cells, especially macrophages and lymphocytes, become overactive. These cells produce a powerful inflammatory reaction sometimes called a cytokine storm. When this happens, inflammation may affect the bone marrow, liver, spleen, brain, lungs, and other organs.
One important consequence is that the bone marrow may stop producing blood cells normally. This can lead to low red blood cells, low white blood cells, and low platelets. As a result, a person may develop fatigue, infections, easy bruising, or bleeding.
HLH can also disturb normal liver function, clotting, and metabolism. Doctors often look for patterns such as very high ferritin levels, elevated triglycerides, and low fibrinogen because these findings support the diagnosis. In some cases, HLH appears alongside other serious blood-related disorders, and evaluation may include checking for conditions such as leukemia when clinically appropriate.
Symptoms and Warning Signs
The symptoms of HLH disease can vary by age, cause, and how advanced the condition is. Persistent high fever is one of the most common signs. Many people also develop marked tiredness, poor appetite, weight loss, rash, or a general feeling of being very unwell.
Doctors often find an enlarged spleen or liver on examination or imaging. This may cause fullness, abdominal swelling, or discomfort in the upper abdomen. Yellowing of the skin or eyes can occur if the liver is affected.
Low blood counts may lead to paleness, weakness, frequent infections, or unusual bruising and bleeding. Some people develop swollen lymph nodes, shortness of breath, or fluid buildup due to widespread inflammation.
If HLH involves the nervous system, symptoms may include headaches, confusion, irritability, seizures, trouble walking, or changes in alertness. In infants and young children, symptoms may be less specific and can include poor feeding, fussiness, or failure to thrive.
- Persistent fever
- Enlarged spleen or liver
- Fatigue and weakness
- Bruising or bleeding
- Repeated or severe infections
- Abdominal swelling or discomfort
- Confusion, seizures, or other neurologic symptoms
Causes and Risk Factors
Primary HLH is linked to inherited genetic changes that impair the ability of immune cells to regulate inflammation. This form is more often diagnosed in infants and children, though in some people it may become apparent later. A family history of HLH or unexplained early childhood deaths may raise concern for an inherited form.
Secondary HLH develops when a strong immune trigger pushes the body into an uncontrolled inflammatory response. Common triggers include viral infections such as Epstein-Barr virus, other serious infections, blood cancers such as lymphoma, and autoimmune or autoinflammatory conditions. It may also occur in people whose immune systems are weakened.
Doctors increasingly recognize related syndromes that resemble HLH, including macrophage activation syndrome in rheumatologic disease. Because some triggers are serious on their own, evaluation often aims to identify and treat the cause at the same time as controlling inflammation. In adults, specialists may consider whether the picture overlaps with disorders such as lymphoma.
Risk factors do not guarantee that HLH will occur, but they help guide testing. These may include a known genetic predisposition, a recent severe infection, certain cancers, autoimmune disease, immune suppression, or a history of transplantation.
How HLH Disease Is Diagnosed
Diagnosing HLH disease usually requires combining symptoms, examination findings, and laboratory results rather than relying on a single test. Because HLH may resemble sepsis, severe viral illness, cancer, or autoimmune flare, doctors work carefully to rule out other causes while assessing for HLH criteria.
Blood tests are central to the evaluation. These often include complete blood count, liver function tests, clotting studies, ferritin, triglycerides, fibrinogen, inflammatory markers, and tests for infection. Specialized immune tests may measure natural killer cell function or soluble interleukin-2 receptor levels when available.
Imaging such as ultrasound or CT may help assess an enlarged liver or spleen and look for an underlying trigger. A bone marrow examination may be recommended to check for hemophagocytosis and to evaluate for blood cancers or marrow disorders. Some people also need lumbar puncture or brain imaging if there are neurologic symptoms.
If inherited HLH is suspected, genetic testing can be an important part of diagnosis and family counseling. Because this is a complex condition, care often involves a team approach and may include advanced blood testing and bone marrow transplantation planning when a genetic form is confirmed or severe disease persists.
Treatment Options and Ongoing Care
Treatment for HLH disease has two main goals: to calm the overactive immune response and to treat the trigger causing it. Management depends on the person’s age, overall condition, the organs involved, and whether HLH is primary or secondary. Most patients need hospital-based care, and some require intensive monitoring.
Supportive treatment may include fluids, blood product transfusions, antibiotics or antiviral therapy when infection is suspected, and treatment for organ complications. To reduce inflammation, doctors may use corticosteroids and other immune-modifying medicines. In some situations, chemotherapy-based protocols or targeted therapies are used under specialist supervision.
If HLH is driven by an underlying disease, treating that cause is essential. This may include therapy for infection, autoimmune disease, or a blood cancer. Depending on the diagnosis, care can involve chemotherapy or a tailored immunology and hematology plan.
For some patients, especially those with inherited HLH or recurring disease, stem cell transplantation may offer the best chance of long-term control. Follow-up is important because recovery can take time, blood tests must be monitored closely, and treatment side effects need attention. Near the end of the care pathway, multidisciplinary specialists at Acibadem International and its JCI-accredited hospitals also diagnose and treat HLH for international patients when advanced evaluation is needed.
Living With HLH: Prevention, Self-care, and Follow-up
There is no general way to prevent all cases of HLH disease because many cases are related to genetic factors or unpredictable immune triggers. However, once HLH is suspected or diagnosed, close follow-up can help detect complications early and support safer recovery.
Patients and families can help by keeping scheduled appointments, reporting new symptoms promptly, and understanding the purpose of blood tests and monitoring. During recovery, doctors may recommend infection precautions, nutrition support, physical rehabilitation, or mental health support depending on the person’s needs.
For families affected by inherited HLH, genetic counseling may be useful. It can help explain recurrence risk, testing for relatives, and future family planning. When treatment is prolonged, it is also important to ask about vaccinations, school or work return, and how to manage fatigue after hospitalization.
Self-care should not replace medical treatment in HLH. This condition requires specialist management, but good communication, rest, hydration, balanced nutrition, and attention to emotional well-being can support the overall treatment plan.
When to Seek Medical Care
Prompt medical care is important if a child or adult has persistent fever, unusual bruising or bleeding, severe weakness, confusion, seizures, or rapid worsening after an infection or inflammatory illness. These symptoms do not always mean HLH, but they do need urgent assessment.
Anyone already being evaluated for HLH should seek immediate help if symptoms suddenly worsen, breathing becomes difficult, urine output drops, or there are signs of significant dehydration or reduced alertness. Because HLH can affect several organs at once, changes can become serious quickly.
People with known risk factors, such as an inherited immune disorder, active lymphoma, or severe infection, should discuss concerning symptoms early with their doctor. If a specialist team is involved, they may coordinate additional testing such as pediatric hematology or adult hematology assessment depending on age and clinical needs.
Frequently asked questions
Is HLH disease a cancer?
HLH disease itself is not a cancer. It is an immune system disorder in which inflammation becomes uncontrolled. However, HLH can be triggered by certain cancers, especially blood cancers such as lymphoma or leukemia.
Can adults get HLH disease, or is it only seen in children?
HLH can affect both children and adults. Inherited forms are more often recognized in infants and children, while adults more commonly develop HLH secondary to infection, cancer, or autoimmune disease. The diagnosis may be more difficult in adults because symptoms overlap with other serious illnesses.
What is usually the first sign of HLH?
Persistent fever is one of the most common early signs. Other early findings may include fatigue, enlarged spleen, low blood counts, or abnormal liver tests. Because these symptoms are not specific, doctors use a combination of clues rather than one symptom alone.
Is HLH disease curable?
Some cases of HLH can be brought under control, especially when the trigger is found and treated quickly. In inherited or recurrent HLH, stem cell transplantation may be considered for long-term disease control. Outcomes vary, so individualized care from an experienced medical team is important.
How long does HLH treatment last?
Treatment length depends on the cause, severity, and response to therapy. Some people need urgent hospital treatment for days to weeks, followed by longer monitoring. Others, especially those with genetic HLH, may require extended treatment plans and transplant evaluation.
Can HLH come back after treatment?
Yes, HLH can recur in some patients, particularly if the underlying trigger is not fully controlled or if there is an inherited form. This is why close follow-up and repeated blood tests are often needed after the initial illness improves. Any return of fever or worsening symptoms should be reported promptly.
References
- National Institutes of Health
- National Organization for Rare Disorders
- American Society of Hematology
- MedlinePlus
- Genetic and Rare Diseases Information Center
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Explore treatments in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
